BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6325737)

  • 1. [Clinical studies of cefotiam in otorhinolaryngologic infections].
    Satake K; Tanino T; Naito T; Osafune H; Komatsuzaki A
    Jpn J Antibiot; 1983 Oct; 36(10):2683-7. PubMed ID: 6325737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical studies of cefotiam in the field of otorhinolaryngology].
    Takeda K; Yoshida M; Ishida T
    Jpn J Antibiot; 1983 Oct; 36(10):2715-20. PubMed ID: 6325741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies of cefotiam in otorhinolaryngologic infections].
    Sato F; Tachibana M; Saito H; Mizukoshi O; Nishimura T; Saito A; Nakamura A; Okawa K; Takenouchi S; Yanohara K
    Jpn J Antibiot; 1983 Oct; 36(10):2688-92. PubMed ID: 6325738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with cefotiam in otorhinolaryngologic infections].
    Yajin K; Harada Y; Takeuchi M; Chikuya D; Noda M; Hirata K
    Jpn J Antibiot; 1983 Oct; 36(10):2721-9. PubMed ID: 6325742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experience with cefotiam in the otorhinolaryngologic field].
    Sugiyama M; Goto K; Ohashi Y; Nakai Y
    Jpn J Antibiot; 1983 Oct; 36(10):2711-4. PubMed ID: 6325740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical effect of a cephalosporin derivative, cefotiam, on otorhinolaryngologic infections].
    Baba S; Wada K; Hatano T; Kinoshita H; Sugimori H; Sasaki T; Miyano K; Maruyama H; Takimoto I; Inafuku S
    Jpn J Antibiot; 1983 Oct; 36(10):2693-710. PubMed ID: 6325739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effect of cefotiam on otorhinolaryngologic infections].
    Nakashima T; Makishima K; Toriya Y; Murata Y; Watanabe H; Kannae S
    Jpn J Antibiot; 1983 Oct; 36(10):2733-41. PubMed ID: 6325744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental and clinical studies of cefotiam for the treatment of otorhinolaryngological infections].
    Furuta S; Obata E; Hanamure Y; Fukuda K; Fukami K; Ohyama M
    Jpn J Antibiot; 1983 Oct; 36(10):2742-9. PubMed ID: 6325745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial potency of cefotiam based on the clinical effect, MIC and decrement of organisms in the sputum].
    Kawagoe M; Narushima K; Kitani A; Shibuya T; Hara M; Hosono K; Shitara M
    Jpn J Antibiot; 1983 Aug; 36(8):2053-7. PubMed ID: 6317912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with cefotiam infusions in chronic sinusitis and otitis media].
    Futaki T; Oda M
    Jpn J Antibiot; 1983 Oct; 36(10):2675-82. PubMed ID: 6325736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with cefotiam (author's transl)].
    Kanai A; Mori M
    Jpn J Antibiot; 1981 May; 34(5):686-9. PubMed ID: 6270410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical experience with cefotiam in pediatric infections (author's transl)].
    Yanagisawa K; Ichihashi H
    Jpn J Antibiot; 1981 May; 34(5):705-10. PubMed ID: 6270412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical investigation of cefotiam against infections complicated by acute leukemia].
    Tsuchiya J; Murakami H; Okamoto K; Nemoto K; Omine M; Maekawa T
    Jpn J Antibiot; 1982 May; 35(5):1167-71. PubMed ID: 6290701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the efficacy of ceftriaxone in acute suppurative otitis media and acute exacerbation of chronic suppurative otitis media. A comparative study with cefotiam as the control].
    Baba S; Mori Y; Suzuki K; Unno T; Kawabori S; Yanai T; Nonaka S; Takasaka T; Awataguchi T; Furuuchi I
    Jpn J Antibiot; 1989 Jan; 42(1):212-47. PubMed ID: 2523493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience with cefotiam in the field of pediatrics (author's transl)].
    Takashima Y; Hatano T; Tauchi N; Maki T; Uozumi K; Kawamura M
    Jpn J Antibiot; 1981 May; 34(5):651-4. PubMed ID: 6270404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical bacteriological studies on cefotiam and cefsulodin in the field of otorhinolaryngology].
    Deguchi K; Fukayama S; Nishimura Y
    Jpn J Antibiot; 1982 May; 35(5):1187-98. PubMed ID: 6290705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of cefotiam in internal medicine].
    Kawamura S; Sakata Y; Chiba Y; Yoshida Y; Aizawa M; Nara H; Yanagiya S; Fukushi K; Ohmi T; Okamoto K; Komatsu Y; Haneda Y; Tanabe K; Segawa M; Yamagata A; Kawatsu S
    Jpn J Antibiot; 1982 May; 35(5):1136-44. PubMed ID: 6290697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies of S6472 in otorhinolaryngologic infections].
    Baba S; Kinoshita H; Mori Y; Suzuki K; Ohyama M; Katsuta K; Furuta S; Ohno I; Noboru T; Yamamoto M
    Jpn J Antibiot; 1985 Jul; 38(7):1750-60. PubMed ID: 4068219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical investigation of cefotiam in combination with aminoglycoside or (and) penicillin against complicated infections with hematopoietic disorders].
    Uno N; Minami N; Tanaka I; Katayama N; Kamio N; Kataoka Y; Ota C; Koh T; Ono T; Kageyama S
    Jpn J Antibiot; 1984 May; 37(5):807-16. PubMed ID: 6090722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laboratory and clinical investigations of cefotiam in surgical biliary tract infections].
    Oikawa M; Watanabe I
    Jpn J Antibiot; 1982 May; 35(5):1153-62. PubMed ID: 6290699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.